Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Agenus Inc. (AGEN)

-NasdaqCM
3.52 Down 0.32(8.33%) Apr 29, 4:00PM EDT
|Pre-Market : 3.57 Up 0.05 (1.42%) 8:23AM EDT
Prev Close:3.84
Open:3.85
Bid:3.53 x 2500
Ask:3.57 x 1700
1y Target Est:10.40
Beta:1.73248
Earnings Date:Jul 21 - Jul 25 (Est.)
Day's Range:3.44 - 3.96
52wk Range:2.61 - 10.16
Volume:1,530,259
Avg Vol (3m):1,237,710
Market Cap:304.58M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 8.33%304.58M
ABPI 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):17.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.20
Quarterly EPS Est (Jun-16) :-0.33
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback